Trakhanov S, Quiocho F A
Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030, USA.
Protein Sci. 1995 Sep;4(9):1914-9. doi: 10.1002/pro.5560040925.
We have tested the effect of several cations in attempts to crystallize the ligand-bound forms of the leucine/isoleucine/valine-binding protein (LIVBP) (M(r) = 36,700) and leucine-specific binding protein (LBP) (M(r) = 37,000), which act as initial periplasmic receptors for the high-affinity osmotic-shock-sensitive active transport system in bacterial cells. Success was achieved with Cd2+ promoting the most dramatic improvement in crystal size, morphology, and diffraction quality. This comes about 15 years after the ligand-free proteins were crystallized. Nine other different divalent cations were tried as additives in the crystallization of LIVBP with polyethylene glycol 8000 as precipitant, and each showed different effects on the crystal quality and morphology. Cd2+ produced large hexagonal prism crystals of LIVBP, whereas a majority of the cations resulted in less desirable needle-shaped crystals. Zn2+ gave crystals that are long rods with hexagonal cross sections, a shape intermediate between the hexagonal prism and needle forms. The concentration of Cd2+ is critical. The best crystals of the LIVBP were obtained in the presence of 1 mM CdCl2, whereas those of LBP, with trigonal prism morphology, were obtained at a much higher concentration of 100 mM. Both crystals diffract to at least 1.7 A resolution using a conventional X-ray source.
我们测试了几种阳离子的作用,试图使亮氨酸/异亮氨酸/缬氨酸结合蛋白(LIVBP)(分子量 = 36,700)和亮氨酸特异性结合蛋白(LBP)(分子量 = 37,000)的配体结合形式结晶,这两种蛋白是细菌细胞中高亲和力渗透休克敏感主动运输系统的初始周质受体。使用Cd2+取得了成功,它使晶体尺寸、形态和衍射质量有了最显著的改善。这是在无配体蛋白结晶约15年后实现的。在以聚乙二醇8000作为沉淀剂使LIVBP结晶的过程中,尝试了其他九种不同的二价阳离子作为添加剂,每种阳离子对晶体质量和形态都有不同的影响。Cd2+产生了LIVBP的大六角棱柱晶体,而大多数阳离子导致形成不太理想的针状晶体。Zn2+得到的晶体是具有六边形横截面的长棒状,形状介于六角棱柱和针状之间。Cd2+的浓度至关重要。LIVBP的最佳晶体是在1 mM CdCl2存在下获得的,而具有三角棱柱形态的LBP晶体是在100 mM的高得多的浓度下获得的。使用传统X射线源时,两种晶体的衍射分辨率至少为1.7 Å。